(19)
(11) EP 2 429 455 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
15.12.2021 Bulletin 2021/50

(45) Mention of the grant of the patent:
10.11.2021 Bulletin 2021/45

(21) Application number: 10719493.8

(22) Date of filing: 28.04.2010
(51) International Patent Classification (IPC): 
A61F 2/24(2006.01)
(52) Cooperative Patent Classification (CPC):
A61F 2/2418; A61F 2/2436; A61F 2220/0008; A61F 2220/005; A61F 2220/0066; A61F 2230/0054; A61F 2230/0078; A61F 2250/006
(86) International application number:
PCT/US2010/032844
(87) International publication number:
WO 2010/127041 (04.11.2010 Gazette 2010/44)

(54)

APPARATUS FOR REPLACING A DISEASED CARDIAC VALVE

VORRICHTUNG FÜR DEN ERSATZ EINER DEFEKTEN HERZKLAPPE

APPAREIL POUR REMPLACER UNE VALVULE CARDIAQUE MALADE

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

(30) Priority: 29.04.2009 US 173782 P

(43) Date of publication of application:
21.03.2012 Bulletin 2012/12

(60) Divisional application:
21206776.3

(73) Proprietor: Edwards Lifesciences Corporation
Irvine, CA 92614-5688 (US)

(72) Inventors:
  • NAVIA, Jose, Luis
    Shaker Heights OH 44122 (US)
  • CHEN, Ji-Feng
    Lakewood OH 44107 (US)
  • ZHOU, Qun
    Lakewood OH 44107 (US)

(74) Representative: Mewburn Ellis LLP 
Aurora Building Counterslip
Bristol BS1 6BX
Bristol BS1 6BX (GB)


(56) References cited: : 
EP-A1- 1 849 440
WO-A2-02/100297
WO-A2-2008/029296
US-A1- 2005 182 486
US-A1- 2007 100 435
 WO-A1-2009/091965
WO-A2-2006/128185
WO-A2-2008/089365
US-A1- 2006 058 872
US-A1- 2007 162 107
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).